Appili Therapeutics Inc (OP: APLIF )
0.0291
+0.0030
(+11.49%)
Streaming Delayed Price
Updated: 9:40 AM EDT, Aug 30, 2024
Add to My Watchlist
Press Releases about Appili Therapeutics Inc
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
From Aditxt, Inc.
Via Business Wire
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://mms.businesswire.com/media/20231214085362/en/1766499/22/Appili_Logo.jpg)
![](https://mms.businesswire.com/media/20231113109537/en/1766499/22/Appili_Logo.jpg)
![](https://mms.businesswire.com/media/20231025902792/en/1766499/22/Appili_Logo.jpg)
![](https://mms.businesswire.com/media/20230927413073/en/1766499/22/Appili_Logo.jpg)
![](https://mms.businesswire.com/media/20230926093626/en/1766499/22/Appili_Logo.jpg)
Appili Therapeutics Presents at the 10th International Tularemia Conference
September 27, 2023
Via Business Wire
![](https://mms.businesswire.com/media/20230925938803/en/1766499/22/Appili_Logo.jpg)
![](https://mms.businesswire.com/media/20230811690167/en/1766499/22/Appili_Logo.jpg)
![](https://mms.businesswire.com/media/20230623613835/en/1766499/22/Appili_Logo.jpg)
Appili Therapeutics – Press Release Correction
June 23, 2023
Via Business Wire
![](https://mms.businesswire.com/media/20230622885165/en/1766499/22/Appili_Logo.jpg)
![](https://mms.businesswire.com/media/20230523006150/en/1766499/22/Appili_Logo.jpg)
![](https://mms.businesswire.com/media/20230417005907/en/1766499/22/Appili_Logo.jpg)
![](https://mms.businesswire.com/media/20230401005043/en/1218134/5/Appili_Logo.jpg)
![](https://mms.businesswire.com/media/20230213005679/en/1218134/5/Appili_Logo.jpg)
![](https://mms.businesswire.com/media/20230117005675/en/1218134/5/Appili_Logo.jpg)
![](https://mms.businesswire.com/media/20230112005901/en/1218134/5/Appili_Logo.jpg)
![](https://mms.businesswire.com/media/20221113005149/en/1218134/5/Appili_Logo.jpg)
![](https://mms.businesswire.com/media/20221109006155/en/1218134/5/Appili_Logo.jpg)
![](https://mms.businesswire.com/media/20220922005885/en/1218134/5/Appili_Logo.jpg)
Appili Therapeutics Announces Results of Annual and Special Meeting of Shareholders
September 22, 2022
Via Business Wire
![](https://mms.businesswire.com/media/20220812005408/en/1218134/5/Appili_Logo.jpg)
![](https://mms.businesswire.com/media/20220801005883/en/1218134/5/Appili_Logo.jpg)
![](https://mms.businesswire.com/media/20220628006208/en/1218134/5/Appili_Logo.jpg)
![](https://mms.businesswire.com/media/20220426006338/en/1218134/5/Appili_Logo.jpg)
![](https://mms.businesswire.com/media/20220412006175/en/1218134/5/Appili_Logo.jpg)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.